|
SFT2D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.96150000000484E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01049999995584E-06 |
| Normal-vs-Stage2 |
4.615600E-02 |
| Normal-vs-Stage3 |
1.204760E-01 |
| Normal-vs-Stage4 |
5.209000E-01 |
| Stage1-vs-Stage2 |
1.086640E-01 |
| Stage1-vs-Stage3 |
1.876170E-02 |
| Stage1-vs-Stage4 |
2.764500E-02 |
| Stage2-vs-Stage3 |
6.897400E-01 |
| Stage2-vs-Stage4 |
3.760000E-01 |
| Stage3-vs-Stage4 |
6.081400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89060000000052E-05 |
| Normal-vs-AfricanAmerican |
3.217400E-03 |
| Normal-vs-Asian |
3.023200E-01 |
| Caucasian-vs-AfricanAmerican |
3.069200E-01 |
| Caucasian-vs-Asian |
4.529200E-01 |
| AfricanAmerican-vs-Asian |
7.059600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.2116000005007E-07 |
| Normal-vs-Female |
3.067700E-02 |
| Male-vs-Female |
1.586320E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.956500E-03 |
| Normal-vs-Extreme_Weight |
3.67619999996904E-07 |
| Normal-vs-Obese |
4.980000E-03 |
| Normal-vs-Extreme_Obese |
3.404700E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.918000E-02 |
| Normal_Weight-vs-Obese |
9.955200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.332600E-01 |
| Extreme_Weight-vs-Obese |
2.079500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.245800E-01 |
| Obese-vs-Extreme_Obese |
2.019000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.095800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.636500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.87540000001962E-06 |
| Normal-vs-Age(81-100Yrs) |
3.799800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.536200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.115610E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.148400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.143600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.858600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.948000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.64630000024191E-07 |
| Normal-VS-Type2 PRCC |
6.075900E-03 |
| Normal-VS-KIRP CIMP |
4.109000E-01 |
| Normal-VS-Unclassified PRCC |
1.989010E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.183190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.943900000003E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.148200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.324450E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.600810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.335950E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.99859999999919E-05 |
| Normal-vs-N1 |
5.386600E-01 |
| Normal-vs-N2 |
5.840000E-03 |
| N0-vs-N1 |
2.224400E-03 |
| N0-vs-N2 |
2.772800E-01 |
| N1-vs-N2 |
2.395900E-02 |
|
|
